Tinea Pedis
📧 Sign up to get email alerts when something new happens for Tinea Pedis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Atmospheric Pressure Cold Plasma for Moderate-to-severe Tinea Pedis [NA]
A clinical trial is recruiting to evaluate atmospheric pressure cold plasma as a treatment for moderate-to-severe tinea pedis (athlete's foo…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Topical Tolnaftate Stick for Tinea Pedis: An Open-Label Interventional Study [Phase 2]
An open-label Phase 2 interventional trial evaluating topical tolnaftate sticks for tinea pedis is currently recruiting.
-
FDA approval · 2025-09-12FDA Approved: TERBINAFINE HYDROCHLORIDE — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Terbinafine hydrochloride from Bionpharma Inc., approving a generic antifungal product under the…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Sports Nutrition Assessment Program
A University of Alicante clinical trial is exploring a sports nutrition assessment program focusing on diet habits and body weight; recruitm…
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: A Trial to Evaluate the Safety and and Tolerability of DBI-001 in Patients With Tinea Pedis [Phase 2]
A Phase 2 trial evaluating the safety and tolerability of DBI-001 in patients with tinea pedis has completed, with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Advanced Footwear Technology in Federated Athletes
A University of Oviedo-led clinical trial is evaluating advanced footwear technology for athletes with athlete's foot, currently not recruit…
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Efficacy of Tropical Sertaconazole Nitrate 2% Vs Clotrimazole 1% for Tinea Pedis [Phase 4]
Phase 4 trial comparing topical sertaconazole nitrate 2% with clotrimazole 1% for tinea pedis; currently not recruiting.
-
FDA approval · 2025-03-07FDA Approved: KETOCONAZOLE — Original Application (Viona Pharmaceuticals Inc)
FDA approves the Original Application for Ketoconazole submitted by Viona Pharmaceuticals Inc, granting approval of a generic ketoconazole p…
-
FDA label_change · 2025-03-06FDA Approved: CICLOPIROX OLAMINE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for Ciclopirox Olamine filed by Padagis Israel Pharmaceuticals Ltd, resulting in changes to the prod…
-
FDA approval · 2024-12-20FDA Approved: TERBINAFINE HYDROCHLORIDE — Supplemental Application (Breckenridge Pharmaceutical, Inc.)
FDA approved a supplemental application for a generic Terbinafine hydrochloride product from Breckenridge Pharmaceutical, Inc.
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Spread of Dermatophytes Among Families
This completed clinical trial investigates the spread of dermatophyte infections within families and has posted results.
-
FDA approval · 2024-09-16FDA Approved: KETOCONAZOLE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' original application for a generic ketoconazole product.
-
FDA approval · 2024-07-10FDA Approved: LOTRIMIN ULTRA ATHLETES FOOT — Supplemental Application (Bayer Healthcare LLC.)
FDA approved a supplemental application for Lotrimin Ultra Athletes Foot (butenafine hydrochloride) submitted by Bayer Healthcare LLC, resul…
-
FDA approval · 2024-04-19FDA Approved: LOTRIMIN ULTRA ATHLETES FOOT — Supplemental Application (Bayer Healthcare LLC.)
FDA approved a supplemental application for Lotrimin Ultra Athletes Foot (butenafine hydrochloride) by Bayer Healthcare LLC. This action com…
-
FDA approval · 2024-02-29FDA Approved: CLOTRIMAZOLE — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved the original application for clotrimazole from Rising Pharma Holdings, enabling a generic version of this antifungal. It co…
-
FDA approval · 2024-01-02FDA Approved: LOTRIMIN ULTRA ATHLETES FOOT — Supplemental Application (Bayer Healthcare LLC.)
The FDA approved a supplemental application for Lotrimin Ultra Athletes Foot (butenafine hydrochloride) submitted by Bayer Healthcare LLC.
-
FDA approval · 2023-10-16FDA Approved: CLOTRIMAZOLE TOPICAL SOLUTION USP, 1% — Original Application (Allegis Holdings, LLC)
The FDA approved Allegis Holdings' clotrimazole topical solution 1% under an Original Application (ANDA), making a generic clotrimazole topi…
-
FDA approval · 2023-08-29FDA Approved: LOTRIMIN ULTRA ATHLETES FOOT — Supplemental Application (Bayer Healthcare LLC.)
The FDA approved a supplemental NDA for Lotrimin Ultra Athletes Foot (butenafine hydrochloride) from Bayer Healthcare LLC.
-
CLINICAL_TRIALS trial_result · 2023-02-14Clinical Trial Update: A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis [Phase 2]
Phase 2 trial evaluating safety and efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel for tinea pedis is in progress with status unknown…
-
FDA approval · 2021-11-12FDA Approved: NAFTIFINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for naftifine hydrochloride submitted by Sun Pharmaceutical Industries, Inc. This action updates…
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis [Phase 2]
Phase 2 study evaluating UHE-103 Cream in subjects with Moccasin Type Tinea Pedis has completed.
-
FDA label_change · 2021-10-18FDA Approved: LOTRIMIN ULTRA ATHLETES FOOT — Supplemental Application (Bayer Healthcare LLC.)
FDA approved a supplemental labeling update for Lotrimin Ultra Athletes Foot (butenafine hydrochloride) by Bayer Healthcare LLC.
-
FDA approval · 2021-05-21FDA Approved: KETOCONAZOLE — Original Application (Xiromed, LLC)
FDA has approved Xiromed, LLC's original generic application for Ketoconazole Foam, a topical antifungal 2% product.
-
FDA approval · 2021-05-20FDA Approved: KETOCONAZOLE — Original Application (Encube Ethicals, Inc.)
FDA approves Encube Ethicals' ketoconazole cream, 2% as an original-application generic topical antifungal product (ANDA212443).
-
FDA approval · 2020-12-15FDA Approved: LOTRIMIN ULTRA ATHLETES FOOT — Supplemental Application (Bayer Healthcare LLC.)
The FDA granted a supplemental approval for Lotrimin Ultra Athletes Foot (butenafine hydrochloride) submitted by Bayer Healthcare LLC.